- Immunization:
- IM 0.5mL x1 at 2 months, 4 months, 6 months, 15-18 months and 4-6 years for 5 total doses
- Not approved for >7 years
Injection: Each single 0.5ml contains:
- Diphtheria Toxoid ≤ 25 Lf (≥ 30 IU)
- Tetanus Toxoid ≥ 5 Lf (≥ 40 IU)
- Bordetella Pertussis ≤ 16 OU (≥ 4 IU)
None remarkable
Vaccines
Induces antibody formation to tetanus, diphtheria and pertussis (active immunity)
- Irritability
- Injection site reaction
- Myalgia
- Drowsiness
- Anorexia
- Fever
- Vomiting
- Hypersensitivity to components
- Encephalopathy within 7 days after prior pertussis vaccine use
- Belimumab
- Interferon gamma 1b
Drug Status
| Availability | Prescription only |
| Pregnancy | Only indicated in peds |
| Breastfeeding | Only indicated in peds |
| Schedule | Not controlled |
| BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
|---|---|---|---|---|---|
| Diphtheria Tetanus And Pertussis Vaccine Adsorbed | FDC | Injection | 10D | Serum Institute of India | Sai Pharma |
| Shan 5 | FDC | Pre-Filled Syringe | 10D | Sanofi Healthcare | Ressourcethica Kenya |